Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2009 1
2010 1
2011 2
2012 1
2014 1
2017 1
2018 1
2019 2
2020 2
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Dihydroergotamine (DHE) - Then and Now: A Narrative Review.
Silberstein SD, Shrewsbury SB, Hoekman J. Silberstein SD, et al. Among authors: hoekman j. Headache. 2020 Jan;60(1):40-57. doi: 10.1111/head.13700. Epub 2019 Nov 17. Headache. 2020. PMID: 31737909 Free PMC article.
Positron Emission Tomography Assessment of the Intranasal Delivery Route for Orexin A.
Van de Bittner GC, Van de Bittner KC, Wey HY, Rowe W, Dharanipragada R, Ying X, Hurst W, Giovanni A, Alving K, Gupta A, Hoekman J, Hooker JM. Van de Bittner GC, et al. Among authors: hoekman j. ACS Chem Neurosci. 2018 Feb 21;9(2):358-368. doi: 10.1021/acschemneuro.7b00357. Epub 2017 Nov 7. ACS Chem Neurosci. 2018. PMID: 29035509
STOP 101: A Phase 1, Randomized, Open-Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD® ) Device, in Healthy Adult Subjects.
Shrewsbury SB, Jeleva M, Satterly KH, Lickliter J, Hoekman J. Shrewsbury SB, et al. Among authors: hoekman j. Headache. 2019 Mar;59(3):394-409. doi: 10.1111/head.13476. Epub 2019 Jan 19. Headache. 2019. PMID: 30659611 Clinical Trial.
Intranasal tat alters gene expression in the mouse brain.
Pulliam L, Sun B, Rempel H, Martinez PM, Hoekman JD, Rao RJ, Frey WH 2nd, Hanson LR. Pulliam L, et al. Among authors: hoekman jd. J Neuroimmune Pharmacol. 2007 Mar;2(1):87-92. doi: 10.1007/s11481-006-9053-z. Epub 2007 Jan 9. J Neuroimmune Pharmacol. 2007. PMID: 18040830
14 results